ADMA News and Press, ADMA Biologics Inc From 09/03/20

ImmunoRank Offers a Faster, Simpler, More Cost Effective Way to Identify High Titer Convalescent Plasma for Use in Both Treating COVID-19 Patients and for Creating COVID-19 Hyperimmune Globulins Proprietary Assay Developed in Collaboration with Leinco Technologies RAMSEY, N.J. and ...

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived b...

"Convalescent plasma should not be considered standard of care for the treatment of patients with COVID-19," says the NIH . "There are currently no data from well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety of convalescent plasma for th...

The chief of the FDA is willing to bypass the full federal approval process in order to make a COVID-19 vaccine available as soon as possible. More news on: Kamada Ltd., Grifols, S.A., XBiotech Inc., Healthcare stocks news Read more ...

Investors in convalescent plasma players have experienced a bit of volatility of late related to the FDA emergency use nod to treat COVID-19 patients. More news on: Kamada Ltd., Grifols, S.A., XBiotech Inc., Healthcare stocks news, Read more ...

The number of authorized coronavirus treatment options increased by one over the weekend, and the market's already pushing up shares of companies that could see a related revenue bump. The Food and Drug Administration's recent emergency use authorization (EUA) of convalescent plasma for the trea...

White House press secretary Kayleigh McEnany tweeted on Saturday that President Trump would hold a news conference on Sunday evening related to a "major therapeutic breakthrough" in treating COVID-19. Only hours before that news conference, the U.S. Food and Drug Administration (FDA) issued an ...

Top 3 Convalescent Plasma Stocks To Watch Before September 2020 There’s no doubt biotech stocks have been grabbing headlines since the novel coronavirus outbreak this year. Specifically, top biotech stocks to buy this year such as Novavax ( NVAX Stock Report ) and Moderna ( MRNA Sto...

Gainers:  Cancer Genetics (NASDAQ: CGIX ) +142% . More news on: Cancer Genetics, Inc., iBio, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...

At a news conference Sunday, President Donald Trump announced that the Food and Drug Administration issued an emergency use authorization (EUA) for convalescent plasma therapy as a treatment for hospitalized COVID-19 patients. Convalescent plasma is the liquid component of blood containing antib...